These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22876296)

  • 21. A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial.
    Duffy L; Bacon F; Clarke CS; Donkor Y; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Lewis G; Mangin D; Marston L; Moore M; Nazareth I; Wiles N; Lewis G
    Trials; 2019 Jun; 20(1):319. PubMed ID: 31159856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani].
    Gaillard R
    Encephale; 2009 Oct; 35(5):499-504. PubMed ID: 19853726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of escitalopram for generalized anxiety disorder in Canada.
    Iskedjian M; Walker JH; Bereza BG; Le Melledo JM; Einarson TR
    Curr Med Res Opin; 2008 May; 24(5):1539-48. PubMed ID: 18416886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness evaluation in Sweden of escitalopram compared with venlafaxine extended-release as first-line treatment in major depressive disorder.
    Nordström G; Danchenko N; Despiegel N; Marteau F
    Value Health; 2012; 15(2):231-9. PubMed ID: 22433753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom.
    Wade AG; Toumi I; Hemels ME
    Clin Ther; 2005 Apr; 27(4):486-96. PubMed ID: 15922821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece.
    Maniadakis N; Kourlaba G; Mougiakos T; Chatzimanolis I; Jonsson L
    BMC Health Serv Res; 2013 May; 13():173. PubMed ID: 23663281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of antidepressants in depression: A systematic review and meta-analysis.
    Yuan Z; Chen Z; Xue M; Zhang J; Leng L
    J Clin Neurosci; 2020 Oct; 80():169-181. PubMed ID: 33099342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of escitalopram versus citalopram in the treatment of severe depression.
    Hemels ME; Kasper S; Walter E; Einarson TR
    Ann Pharmacother; 2004 Jun; 38(6):954-60. PubMed ID: 15113989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy.
    Mencacci C; Di Sciascio G; Katz P; Ripellino C
    Clinicoecon Outcomes Res; 2013; 5():87-99. PubMed ID: 23413176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder.
    Fernandez JL; Montgomery S; Francois C
    Pharmacoeconomics; 2005; 23(2):155-67. PubMed ID: 15748090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the rapid response of an antidepressant contribute to better cost-effectiveness? Comparison between mirtazapine and SSRIs for first-line treatment of depression in Japan.
    Sado M; Wada M; Ninomiya A; Nohara H; Kosugi T; Arai M; Endo R; Mimura M
    Psychiatry Clin Neurosci; 2019 Jul; 73(7):400-408. PubMed ID: 30973181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment.
    Jönsson B; Bebbington PE
    Br J Psychiatry; 1994 May; 164(5):665-73. PubMed ID: 7921718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
    Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost effectiveness of pharmacological treatments for generalized anxiety disorder.
    Mavranezouli I; Meader N; Cape J; Kendall T
    Pharmacoeconomics; 2013 Apr; 31(4):317-33. PubMed ID: 23512146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
    J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial.
    Romeo R; Knapp M; Hellier J; Dewey M; Ballard C; Baldwin R; Bentham P; Burns A; Fox C; Holmes C; Katona C; Lawton C; Lindesay J; Livingston G; McCrae N; Moniz-Cook E; Murray J; Nurock S; O'Brien J; Poppe M; Thomas A; Walwyn R; Wilson K; Banerjee S
    Br J Psychiatry; 2013 Feb; 202():121-8. PubMed ID: 23258767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria.
    Brown MC; Nimmerrichter AA; Guest JF
    Eur Psychiatry; 1999 Jul; 14(4):230-44. PubMed ID: 10572352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacoeconomic analysis of antidepressants for major depressive disorder in the United Kingdom.
    Freeman H; Arikian S; Lenox-Smith A
    Pharmacoeconomics; 2000 Aug; 18(2):143-8. PubMed ID: 11067648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database.
    Coupland CA; Dhiman P; Barton G; Morriss R; Arthur A; Sach T; Hippisley-Cox J
    Health Technol Assess; 2011 Aug; 15(28):1-202, iii-iv. PubMed ID: 21810375
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.